5 unchanged sentences
Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in our securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information.
−Removed: During the second quarter of 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
−Removed: Indenture (including form of Note) with respect to the Company’s 6.00% Convertible Senior Notes due 2029, dated May 13, 2024, between the Company, the guarantors party thereto and Wilmington Savings Fund Society, FSB, as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024).
−Removed: Form of Warrant to Purchase Common Stock (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024).
−Removed: Credit Agreement, dated as of May 8, 2024, between the Company, the guarantors party thereto, the lenders party thereto, and Wilmington Savings Fund Society, FSB, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024) .
−Removed: Form of Exchange Agreement, dated May 8, 2024, by and among the Company and the other parties thereto (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024) .
−Removed: Form of Registration Rights Agreement, dated May 13, 2024, by and among the Company and the other parties thereto (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024) .
−Removed: Second Omnibus Amendment to Transaction Documents, dated May 8, 2024, between the Company, the investors party thereto, HealthCare Royalty Management, LLC, HCR Collateral Management LLC, and HCR Karyopharm SPV, LLC (incorporated by reference to Exhibit 10.4 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-36167) filed with the SEC on May 14, 2024) .
−Removed: Amendment No.
−Removed: 2 to the Karyopharm Therapeutics Inc.
−Removed: 2022 Equity Incentive Plan (incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A (File No.
−Removed: 001-36167) filed with the SEC on April 19, 2024).
−Removed: Amendment No.
−Removed: 1 to the Karyopharm Therapeutics Inc.
−Removed: Amended & Restated 2013 Employee Stock Purchase Plan (incorporated herein by reference to Appendix B to the Company’s Definitive Proxy Statement on Schedule 14A (File No.
−Removed: 001-36167) filed with the SEC on April 19, 2024).
+Added: During the third quarter of 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
+Added: Transition Agreement, dated as of August 29, 2024, between the Company and Michael Mason (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-36167) filed with the SEC on August 29, 2024).
+Added: Consulting Agreement, dated as of August 29, 2024, between the Company and Michael Mason (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-36167) filed with the SEC on August 29, 2024).
Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended.
11 unchanged sentences
KARYOPHARM THERAPEUTICS INC.
−Removed: August 6, 2024
+Added: November 5, 2024
/s/ Richard Paulson
2 unchanged sentences
(Principal executive officer)
−Removed: August 6, 2024
+Added: November 5, 2024
/s/ Michael Mason
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.